← Back to Clinical Trials
Recruiting Phase 1 NCT06653400
Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy
Trial Parameters
Condition Abnormal Uterine Bleeding
Sponsor Icahn School of Medicine at Mount Sinai
Study Type INTERVENTIONAL
Phase Phase 1
Enrollment 60
Sex FEMALE
Min Age 18 Years
Max Age N/A
Start Date 2025-02-27
Completion 2026-09-01
All Conditions
Interventions
paracervical blockLidocaineketorolac
Brief Summary
A randomized double-blind placebo controlled trial comparing the effect of a combined ketorolac and lidocaine paracervical block with a standard lidocaine paracervical block on procedure related pain with office hysteroscopies.
Eligibility Criteria
Inclusion Criteria: * Patients assigned female at birth, * booked for office hysteroscopy at Mount Sinai Hospital faculty practice associates. Exclusion Criteria: * Allergy to ketorolac or non-steroidal anti-inflammatory medications * Allergy to lidocaine * Presence of thrombocytopenia * Contraindications to lidocaine * History of gastritis or gastric ulcer * Acute renal failure or chronic renal disease * Chronic liver disease * History of bleeding diathesis * Long term narcotic use
Related Trials
NCT06024109
Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hyster
View Trial →
NCT07496905
The Effect of the Valsalva Maneuver in Endometrial Biopsy: A Randomized Controlled Trial
View Trial →
NCT06653400
Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy
View Trial →